The 18q21 region in colorectal and pancreatic cancer: independent loss of DCC and DPC4 expression
- 18 October 2000
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1502 (2) , 283-296
- https://doi.org/10.1016/s0925-4439(00)00054-5
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Chromosome 18q allelic loss and prognosis in stage II and III colon cancerInternational Journal of Cancer, 1998
- Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancerPublished by Elsevier ,1998
- Prognostic significance of allelic loss at chromosome 18q21 for stage II colorectal cancerGastroenterology, 1998
- Lessons from Hereditary Colorectal CancerCell, 1996
- Allelic Loss of Chromosome 18q and Prognosis in Colorectal CancerNew England Journal of Medicine, 1994
- Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased DCC expression are correlated with the metastatic potentialCancer, 1994
- Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinomaInternational Journal of Cancer, 1993
- Allelic Loss in Colorectal CarcinomaJAMA, 1989
- Allelotype of Colorectal CarcinomasScience, 1989
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988